Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose
Crossref DOI link: https://doi.org/10.1038/bmt.2014.121
Published Online: 2014-06-02
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
dos Santos, K B
Costa, L J
Atalla, A
Pereira, J
Hallack-Neto, A E
Text and Data Mining valid from 2014-06-02
Version of Record valid from 2014-06-02
Article History
First Online: 2 June 2014
Competing interests
: The authors declare no conflict of interest.